Repurposing of Kinase Inhibitors for Treatment of COVID-19

The outbreak of COVID-19, the pandemic disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spurred an intense search for treatments by the scientific community. In the absence of a vaccine, the goal is to target the viral life cycle and alleviate the lung-damaging...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharm Res
Main Authors: Weisberg, Ellen, Parent, Alexander, Yang, Priscilla L., Sattler, Martin, Liu, Qingsong, Liu, Qingwang, Wang, Jinhua, Meng, Chengcheng, Buhrlage, Sara J., Gray, Nathanael, Griffin, James D.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2020
Assuntos:
Expert Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7417114/
https://ncbi.nlm.nih.gov/pubmed/32778962
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11095-020-02851-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados